作者: James T. Dalton , Sunjoo Ahn , Ramesh Narayanan , Mitchell S. Steiner
DOI:
关键词: Oncology 、 Cancer 、 Lapatinib 、 Metastatic breast cancer 、 Breast cancer 、 Triple-negative breast cancer 、 Metastasis 、 Medicine 、 Tamoxifen 、 Toremifene 、 Internal medicine
摘要: This invention relates to the treatment of androgen receptor-positive breast cancer in a subject, for example female subject. Accordingly, this provides methods of: a) treating subject suffering from cancer; b) metastatic c) refractory d) AR-positive e) f) g) and ER-positive h) triple negative i) advanced j) that has failed SERM (tamoxifen, toremifene), aromatase inhibitor, trastuzumab (Herceptin, ado-trastuzumab emtansine), pertuzumab (Perjeta), lapatinib, exemestane (Aromasin), bevacizumab (Avastin), and/or fulvestrant treatments; k) treating, preventing, suppressing or inhibiting metastasis l) prolonging survival with cancer, m) progression-free comprising administering therapeutically effective amount selective receptor modulator (SARM) compound, SARM compound invention.